Difference between revisions of "Minutes - Referral WG 2023-03-03"

From Health Level 7 Belgium Wiki
 
(One intermediate revision by the same user not shown)
Line 4: Line 4:
 
* Bart Decuypere
 
* Bart Decuypere
 
* Bart Reekmans
 
* Bart Reekmans
 +
* Cyprien Janssens
 
* Geert Vandenhole
 
* Geert Vandenhole
* Hans De Keersmaeker
+
* Hans De Keersmaecker
* Jean-Michel Polfliet
 
* Julien Beard
 
 
* Katrien Dickx
 
* Katrien Dickx
 
* Karlien Erauw  
 
* Karlien Erauw  
* Laurent Lamouline
 
* Lionel Cremer
 
 
* Maarten Cobbaert  
 
* Maarten Cobbaert  
 
* Marleen Van Eygen
 
* Marleen Van Eygen
 
* Maxime Daive
 
* Maxime Daive
 +
* Robin Merckx
  
 
=== Excused ===
 
=== Excused ===
Line 20: Line 18:
 
* Benjamien Schmitt  
 
* Benjamien Schmitt  
 
* Christophe Behaegel
 
* Christophe Behaegel
* Cyprien Janssens
 
 
* Dorsan de Fabricheckers
 
* Dorsan de Fabricheckers
 
* Jacques Yakoub
 
* Jacques Yakoub
 
* Jean-Francois Coquelet  
 
* Jean-Francois Coquelet  
 +
* Jean-Michel Polfliet
 
* José Costa Teixeira
 
* José Costa Teixeira
 +
* Julien Beard
 
* Katleen Smedts
 
* Katleen Smedts
 +
* Laurent Lamouline
 +
* Lionel Cremer
 
* Pablo Christiaens
 
* Pablo Christiaens
 
* Pieter Devolder
 
* Pieter Devolder
 
* Philippe Baise
 
* Philippe Baise
 
* Richard Francken  
 
* Richard Francken  
* Robin Merckx
+
 
  
 
=== Agenda ===
 
=== Agenda ===

Latest revision as of 08:12, 10 March 2023

Attendees

  • Anne Nerenhausen
  • Anthony Maton
  • Bart Decuypere
  • Bart Reekmans
  • Cyprien Janssens
  • Geert Vandenhole
  • Hans De Keersmaecker
  • Katrien Dickx
  • Karlien Erauw
  • Maarten Cobbaert
  • Marleen Van Eygen
  • Maxime Daive
  • Robin Merckx

Excused

  • Ben Goosse
  • Benjamien Schmitt
  • Christophe Behaegel
  • Dorsan de Fabricheckers
  • Jacques Yakoub
  • Jean-Francois Coquelet
  • Jean-Michel Polfliet
  • José Costa Teixeira
  • Julien Beard
  • Katleen Smedts
  • Laurent Lamouline
  • Lionel Cremer
  • Pablo Christiaens
  • Pieter Devolder
  • Philippe Baise
  • Richard Francken


Agenda

  • Resolution of issues

Meeting Minutes

  • Valuesets: first version was presented 2 week ago - no update
  • the discipline is a transversal valuesets and is being looked into by some hospitals, valueset comes from Cobhra so no need to review
  • the first version is final and there will be no changes for the first release
  • BodySite is transversal and lead by Anne
  • Annex 81 use case : work awaits steerco decision
  • Issue 5: mapping needs to be done, by Bart
  • Issue 10: remains open, awaiting info from José
  • Issue 47: how to handle duplicates of a service request, is resolved & closed
  • we don't need a link with the original service request for a duplicate so we can drop the third option and close the issue
  • Issue 54: description of custom operations, these will be part of the IG
  • Issue 53: linked to issue 54
  • Issue 52: linked to issue 54
  • no definite list of custom operations available yet - input needed from Anthony, work
  • the idea is to have as few operations as possible
  • Issue 77: linked to bodyparts - needs to be checked by RIZIV/Maarten
  • Issue 126: needs to be checked by RIZIV, linked to use case multiple prescribers
  • Issue 168: is ongoing, will only be closed once all use cases are tackled
  • Issue 187: will remain open, linked to SteerCo committee/RIZIV & afterwards needing info from WG Medication
  • Issue 191: both structure and businessrules can change due to evolutions in the legislation, awaiting a proposal from Anthony in the spirit of looking at HL7 int'l - to decide in WG FHIR infra & scty
  • Issue 205: valueset v1/phase 1 is final so apart from BodySite (transversal) all is resolved
  • where will we put the valueset of Route ? needs to be discussed, linked to feedback from SteerCo
  • Issue 197: valueset v1/phase 1 is final so issue can be closed - please note that there will be updates on the valuesets from time to time though
  • Issue 195: valueset v1/phase 1 is final so issue can be closed - please note that there will be updates on the valuesets from time to time though
  • Issue 194: duplicate to issue 168, so issue can be closed
  • Issue 169: meetings will happen with NIC/CIN led by Maarten, normally there will be an update by next week
  • Issue 167: if value sets are final, this can be closed
  • Issue 149: linked to 205
  • Issue 149: linked to 205
  • Issue 130: who is going to generate the UUID from the prescription - still being looked into by Anthony and an update will be provided in the upcoming weeks
  • Issue 128: linked to issue 130


  • Progress on use cases :
  • use cases are ready on medication administration and blood sample : included in IG
  • on annex 81 awaiting info
  • multiple prescribers : no progress has been made
  • By next week there will be feedback from the Steering committee

Agenda next meeting

  • feedback on use cases
  • input on issues to continue resolution of issues : we will have to assess upfront if we have sufficient additional input by next Friday to be able to have an efficient meeting or not

Next meeting: next week Friday 10 or 17 March at 9AM : to be decided 2 days in advance